An Ontario appellate court on February 21 upheld a landmark decision denying certification of a product liability class action.
In the short oral decision in Martin v AstraZeneca Pharmaceuticals, the Divisional Court of Ontario endorsed the reasons and analysis of Madam Justice Horkins, a lower court judge who had denied certification of a proposed class action involving an anti-psychotic drug. A copy of our previous bulletin on this case can be found here.
In reaching this conclusion, the Divisional Court disagreed with the plaintiff's argument that the lower court judge had inappropriately engaged in a detailed weighing of facts that was not permissible at the certification stage. Instead, the Divisional Court found that Justice Horkins had applied the correct legal test when she concluded that the plaintiff had failed to plead sufficient facts to support the allegations that the defendants had failed to warn class members of risks associated with the drug and had been negligent in the manufacture of it.
The Divisional Court's decision is an important endorsement of the underlying case, which is one of the few cases in which Canadian courts have refused to certify product liability class actions. The Martin v AstraZeneca decision contains a variety of important rulings on product labels, off-label use and the treatment of causation at the certification stage, and the decision not to interfere with the underlying decision is an important development in relation to class actions in Canada.
Norton Rose Group
Norton Rose Group is a leading international legal practice. We offer a full business law service to many of the world's pre-eminent financial institutions and corporations from offices in Europe, Asia, Australia, Canada, Africa, the Middle East, Latin America and Central Asia.
Knowing how our clients' businesses work and understanding what drives their industries is fundamental to us. Our lawyers share industry knowledge and sector expertise across borders, enabling us to support our clients anywhere in the world. We are strong in financial institutions; energy; infrastructure, mining and commodities; transport; technology and innovation; and pharmaceuticals and life sciences.
We have more than 2900 lawyers operating from 43 offices in Abu Dhabi, Almaty, Amsterdam, Athens, Bahrain, Bangkok, Beijing, Bogotá, Brisbane, Brussels, Calgary, Canberra, Cape Town, Caracas, Casablanca, Dubai, Durban, Frankfurt, Hamburg, Hong Kong, Johannesburg, London, Melbourne, Milan, Montréal, Moscow, Munich, Ottawa, Paris, Perth, Piraeus, Prague, Québec, Rome, Shanghai, Singapore, Sydney, Tokyo, Toronto and Warsaw; and from associate offices in Dar es Salaam, Ho Chi Minh City and Jakarta.
Norton Rose Group comprises Norton Rose LLP, Norton Rose Australia, Norton Rose Canada LLP, Norton Rose South Africa (incorporated as Deneys Reitz Inc), and their respective affiliates.
On January 1, 2012, Macleod Dixon joined Norton Rose Group adding strength and depth in Canada, Latin America and around the world. For more information please visit nortonrose.com.
Norton Rose will join forces with Fulbright & Jaworski L.L.P on June 1, 2013, creating Norton Rose Fulbright a global legal practice with significant depth of expertise across the USA, Europe, Asia, Australia, Canada, Africa, the Middle East, Latin America and Central Asia.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
